The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
New CEO and new distribution centre up and running. Inflation coming down and a kitchen ware market open for competition. Stronger pound May mean goods imported will cost a little less.
My modest buy today is showing as a sell.
The company announce a hydrogen electric mobile elevated platform for use in construction industry in conjunction with Niftylift. A 3 year deal for Nifty to manufacture and supply.
Would go well with AFC products if they can be operated simply and without too much technical know how.
Oh dear we are losing ground fast. The company has competent management and some clever products. But like so many AIM stocks the market isn’t interested. Let’s hope we get India production properly off the mark to liven up the share price .
UK banks are in my mind now utility stocks. After the bail out the govt had them punished and profit is an unhealthy word. Despite balance sheets now being stronger than ever and a 5% yield for Lloyds it makes no headway reflecting the dismal prospects for UK plc. And the bank can only shut branches and buy back itself to make any creditable upgrade to its future. Where is the vision and innovation to get this once fit organisation back to £10 a share and a Pitman style culture? Or is that where it went wrong!
Another graphene company who today announce a link up with Italian fashion co using their product in denim.
Shares have been uninspiring but at least they are solvent. Suggest a TKO by them would put Versarien out of their misery?
The RNS states institutions were not prepared to engage with the board over the objections they made to continued appointment of the founders to the board. Perhaps the city boys realised how old Warren Buffet is!!
Of more interest is where the founders shares go on their demise. An attempt at an ethical sale got nowhere so what happens now?